Santen Pharmaceutical Co., Ltd. held its 99th Annual General Meeting of Shareholders for the fiscal year 2010 on June 22, 2011. The Meeting started at 10:00 a.m. and ended at 10:59 a.m. The number of shareholders attended was 180.
- Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 99th Business Term (April 1, 2010 to March 31, 2011)
- Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 99th Business Term ( April 1, 2010 to March 31, 2011)
Question regarding medium-term management plan, sales performance by business segment, sales impact by generic drug, status of new product pipeline, return policy to shareholders were answered.
Six items of business as described below were all resolved.
|Questions||There was no question submitted by shareholders.|